Basic Information
| RNALocate ID: | RLID:11001717 |
| RNA Symbol: | hsa-miR-125b-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-125b-5p |
| RNA ID: | miRBase:MIMAT0000423 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23382797 |
| Tissue/Cell Line: | Brain tissue |
| Method: | Microarray |
| Description: | We performed miRNA expression analysis using a FlexMAP3D instrument by (Luminex Corporation, Austin, TX) and a manufacturer's assay for 312 miRNA (Table S1). Data are collected from Table S1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001753 | Cytoplasm | Neural progenitor cells | 21363885 |
| RLID:01001754 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001755 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001756 | Mitochondrion | Myotube | 27396686 |
| RLID:01001757 | Mitochondrion | Skeletal muscle cells | 27563705 |
| RLID:01001758 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001759 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001760 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001761 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001762 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:11001715 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
| RLID:11001716 | Exosome | Primary dendritic cells | 21505438 |
| RLID:11001718 | Exosome | Plasma | 23663360 |
| RLID:11001719 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
| RLID:11001720 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001721 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11001722 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000076 | Exosome | Blood|Breast milk|Endothelial cells|Epithelial cells|Seminal fluid | |
| RLID-D:11000351 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-125b-5p | Diffuse large b cell lymphoma | MNDR-E-MI-07449 |
| MNDR | hsa-miR-125b-5p | Splenic marginal zone lymphoma | MNDR-E-MI-07450 |
| MNDR | hsa-miR-125b-5p | Colorectal adenoma | MNDR-E-MI-07451 |
| MNDR | hsa-miR-125b-5p | Oral squamous cell carcinoma | MNDR-E-MI-07452 |
| MNDR | hsa-miR-125b-5p | Medulloblastoma | MNDR-E-MI-07453 |
| MNDR | hsa-miR-125b-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-07454 |
| MNDR | hsa-miR-125b-5p | Ovarian clear cell carcinoma | MNDR-E-MI-07455 |
| MNDR | hsa-miR-125b-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-07456 |
| MNDR | hsa-miR-125b-5p | Lymphoma | MNDR-E-MI-07457 |
| MNDR | hsa-miR-125b-5p | Lymphoma non-hodgkin | MNDR-E-MI-07458 |
| MNDR | hsa-miR-125b-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-07459 |
| MNDR | hsa-miR-125b-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-07460 |
| MNDR | hsa-miR-125b-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-07461 |
| MNDR | hsa-miR-125b-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-07462 |
| MNDR | hsa-miR-125b-5p | Her2-receptor positive breast cancer | MNDR-E-MI-07463 |
| MNDR | hsa-miR-125b-5p | Acute promyelocytic leukemia | MNDR-E-MI-07464 |
| MNDR | hsa-miR-125b-5p | Breast cancer luminal | MNDR-E-MI-07465 |
| MNDR | hsa-miR-125b-5p | Anaplastic thyroid cancer | MNDR-E-MI-07466 |
| MNDR | hsa-miR-125b-5p | B-cell acute lymphoblastic leukemia | MNDR-E-MI-07467 |
| MNDR | hsa-miR-125b-5p | Prostate cancer | MNDR-E-MI-07468 |
| MNDR | hsa-miR-125b-5p | Chronic lymphocytic leukemia | MNDR-E-MI-07469 |
| MNDR | hsa-miR-125b-5p | Gastric cancer | MNDR-E-MI-07470 |
| MNDR | hsa-miR-125b-5p | Gastric lymphoma | MNDR-E-MI-07471 |
| MNDR | hsa-miR-125b-5p | Alzheimer disease | MNDR-E-MI-07472 |
| MNDR | hsa-miR-125b-5p | Intracranial aneurysm | MNDR-E-MI-07473 |
| MNDR | hsa-miR-125b-5p | Bladder cancer | MNDR-E-MI-07474 |
| MNDR | hsa-miR-125b-5p | Respiratory distress syndrome adult | MNDR-E-MI-07475 |
| MNDR | hsa-miR-125b-5p | Dysautonomia familial | MNDR-E-MI-07476 |
| MNDR | hsa-miR-125b-5p | Myotonic dystrophy | MNDR-E-MI-07477 |
| MNDR | hsa-miR-125b-5p | Head and neck cancer | MNDR-E-MI-07478 |
| MNDR | hsa-miR-125b-5p | Leukemia | MNDR-E-MI-07479 |
| MNDR | hsa-miR-125b-5p | Ataxia telangiectasia | MNDR-E-MI-07480 |
| MNDR | hsa-miR-125b-5p | Friedreich ataxia | MNDR-E-MI-07481 |
| MNDR | hsa-miR-125b-5p | Huntington disease | MNDR-E-MI-07482 |
| MNDR | hsa-miR-125b-5p | Cardiovascular disease | MNDR-E-MI-07483 |
| MNDR | hsa-miR-125b-5p | Carotid stenosis | MNDR-E-MI-07484 |
| MNDR | hsa-miR-125b-5p | Uterine fibroid | MNDR-E-MI-07485 |
| MNDR | hsa-miR-125b-5p | Lung cancer | MNDR-E-MI-07486 |
| MNDR | hsa-miR-125b-5p | Down syndrome | MNDR-E-MI-07487 |
| MNDR | hsa-miR-125b-5p | Fragile x syndrome | MNDR-E-MI-07488 |
| MNDR | hsa-miR-125b-5p | Parkinson disease | MNDR-E-MI-07489 |
| MNDR | hsa-miR-125b-5p | Machado-joseph disease | MNDR-E-MI-07490 |
| MNDR | hsa-miR-125b-5p | Colonic adenomas | MNDR-E-MI-07491 |
| MNDR | hsa-miR-125b-5p | Breast cancer | MNDR-E-MI-07492 |
| MNDR | hsa-miR-125b-5p | Vascular diseases | MNDR-E-MI-07493 |
| MNDR | hsa-miR-125b-5p | Pituitary neoplasms | MNDR-E-MI-07494 |
| MNDR | hsa-miR-125b-5p | Pancreatic cancer | MNDR-E-MI-07495 |
| MNDR | hsa-miR-125b-5p | Melanoma | MNDR-E-MI-07496 |
| MNDR | hsa-miR-125b-5p | Williams syndrome | MNDR-E-MI-07497 |
| MNDR | hsa-miR-125b-5p | Rectum adenocarcinoma | MNDR-E-MI-07498 |
| MNDR | hsa-miR-125b-5p | Hepatitis B | MNDR-E-MI-07499 |
| MNDR | hsa-miR-125b-5p | Colon cancer | MNDR-E-MI-07500 |
| MNDR | hsa-miR-125b-5p | Colon adenocarcinoma | MNDR-E-MI-07501 |
| MNDR | hsa-miR-125b-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-07502 |
| MNDR | hsa-miR-125b-5p | Ovarian cancer | MNDR-E-MI-07503 |
| MNDR | hsa-miR-125b-5p | Acromegaly | MNDR-E-MI-07504 |
| MNDR | hsa-miR-125b-5p | Cerebellar disease | MNDR-E-MI-07505 |
| MNDR | hsa-miR-125b-5p | Endometrial carcinoma | MNDR-E-MI-07506 |
| MNDR | hsa-miR-125b-5p | Laryngeal squamous cell carcinoma | MNDR-E-MI-07507 |
| MNDR | hsa-miR-125b-5p | Endometriosis | MNDR-E-MI-07508 |
| MNDR | hsa-miR-125b-5p | Thyroid adenomas | MNDR-E-MI-07509 |
| MNDR | hsa-miR-125b-5p | Carcinoma ductal breast | MNDR-E-MI-07510 |
| MNDR | hsa-miR-125b-5p | Glioblastoma | MNDR-E-MI-07511 |
| MNDR | hsa-miR-125b-5p | Astrocytoma | MNDR-E-MI-07512 |
| MNDR | hsa-miR-125b-5p | Glioma | MNDR-E-MI-07513 |
| MNDR | hsa-miR-125b-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-07514 |
| MNDR | hsa-miR-125b-5p | Oligodendroglioma | MNDR-E-MI-07515 |
| MNDR | hsa-miR-125b-5p | Paraparesis tropical spastic | MNDR-E-MI-07516 |
| MNDR | hsa-miR-125b-5p | Chordoma | MNDR-E-MI-07517 |
| MNDR | hsa-miR-125b-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-07518 |
| MNDR | hsa-miR-125b-5p | Epilepsy temporal lobe | MNDR-E-MI-07519 |
| MNDR | hsa-miR-125b-5p | Osteosarcoma | MNDR-E-MI-07520 |
| MNDR | hsa-miR-125b-5p | Liposarcoma | MNDR-E-MI-07521 |
| MNDR | hsa-miR-125b-5p | Breast carcinoma | MNDR-E-MI-07522 |
| MNDR | hsa-miR-125b-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-07523 |
| MNDR | hsa-miR-125b-5p | Meningioma | MNDR-E-MI-07524 |
| MNDR | hsa-miR-125b-5p | Cervical adenocarcinoma | MNDR-E-MI-07525 |
| MNDR | hsa-miR-125b-5p | Gastric adenocarcinoma | MNDR-E-MI-07526 |
| MNDR | hsa-miR-125b-5p | Cervical squamous cell carcinoma | MNDR-E-MI-07527 |
| MNDR | hsa-miR-125b-5p | Pituitary adenoma | MNDR-E-MI-07528 |
| MNDR | hsa-miR-125b-5p | Lung squamous cell carcinoma | MNDR-E-MI-07529 |
| MNDR | hsa-miR-125b-5p | Carcinoma lung non-small-cell | MNDR-E-MI-07530 |
| MNDR | hsa-miR-125b-5p | Lung adenocarcinoma | MNDR-E-MI-07531 |
| MNDR | hsa-miR-125b-5p | Adrenocortical carcinoma | MNDR-E-MI-07532 |
| MNDR | hsa-miR-125b-5p | Thyroid carcinoma | MNDR-E-MI-07533 |
| MNDR | hsa-miR-125b-5p | Ovarian carcinoma | MNDR-E-MI-07534 |
| MNDR | hsa-miR-125b-5p | Bladder urothelial carcinoma | MNDR-E-MI-07535 |
| MNDR | hsa-miR-125b-5p | Pancreatic adenocarcinoma | MNDR-E-MI-07536 |
| MNDR | hsa-miR-125b-5p | Skin cancer | MNDR-E-MI-07537 |
| MNDR | hsa-miR-125b-5p | Cervical cancer | MNDR-E-MI-07538 |
| MNDR | hsa-miR-125b-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-07539 |
| MNDR | hsa-miR-125b-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-07540 |
| MNDR | hsa-miR-125b-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-07541 |
| MNDR | hsa-miR-125b-5p | Renal clear cell carcinoma | MNDR-E-MI-07542 |
| MNDR | hsa-miR-125b-5p | Biliary tract cancer | MNDR-E-MI-07543 |
| MNDR | hsa-miR-125b-5p | Cholangiocarcinoma | MNDR-E-MI-07544 |
| MNDR | hsa-miR-125b-5p | Esophageal cancer | MNDR-E-MI-07545 |
| MNDR | hsa-miR-125b-5p | Liver cirrhosis | MNDR-E-MI-07546 |
| MNDR | hsa-miR-125b-5p | Arteriosclerosis obliterans | MNDR-E-MI-07547 |
| MNDR | hsa-miR-125b-5p | Lung small cell carcinoma | MNDR-E-MI-07548 |
| MNDR | hsa-miR-125b-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-07549 |
| MNDR | hsa-miR-125b-5p | Heart failure | MNDR-E-MI-07550 |
| MNDR | hsa-miR-125b-5p | Aortic valve disease | MNDR-E-MI-07551 |
| MNDR | hsa-miR-125b-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-07552 |
| MNDR | hsa-miR-125b-5p | Fibromyalgia | MNDR-E-MI-07553 |
| MNDR | hsa-miR-125b-5p | Breast invasive carcinoma | MNDR-E-MI-07554 |
| MNDR | hsa-miR-125b-5p | Cerebrovascular disease | MNDR-E-MI-07555 |
| MNDR | hsa-miR-125b-5p | Endometrioid endometrial cancer | MNDR-E-MI-07556 |
| MNDR | hsa-miR-125b-5p | Early hepatocellular carcinoma | MNDR-E-MI-07557 |
| MNDR | hsa-miR-125b-5p | B-cell lymphoma | MNDR-E-MI-07558 |
| MNDR | hsa-miR-125b-5p | Rheumatoid arthritis | MNDR-E-MI-07559 |
| MNDR | hsa-miR-125b-5p | T-cell leukemia | MNDR-E-MI-07560 |
| MNDR | hsa-miR-125b-5p | Retinoblastoma | MNDR-E-MI-07561 |
| MNDR | hsa-miR-125b-5p | Neuroblastoma | MNDR-E-MI-07562 |
| MNDR | hsa-miR-125b-5p | Barrett's adenocarcinoma | MNDR-E-MI-07563 |
| MNDR | hsa-miR-125b-5p | Hodgkin lymphoma | MNDR-E-MI-07564 |
| MNDR | hsa-miR-125b-5p | Burkitt lymphoma | MNDR-E-MI-07565 |
| MNDR | hsa-miR-125b-5p | Tonsil cancer | MNDR-E-MI-07566 |
| MNDR | hsa-miR-125b-5p | Psoriasis | MNDR-E-MI-07567 |
| MNDR | hsa-miR-125b-5p | Skin cutaneous melanoma | MNDR-E-MI-07568 |
| MNDR | hsa-miR-125b-5p | Skin melanoma | MNDR-E-MI-07569 |
| MNDR | hsa-miR-125b-5p | Acute myeloid leukemia | MNDR-E-MI-07570 |
| MNDR | hsa-miR-125b-5p | Gastrointestinal stromal tumor | MNDR-E-MI-07571 |
| MNDR | hsa-miR-125b-5p | Colorectal cancer | MNDR-E-MI-07572 |
| MNDR | hsa-miR-125b-5p | Nasopharynx carcinoma | MNDR-E-MI-07573 |
| MNDR | hsa-miR-125b-5p | Multiple myeloma | MNDR-E-MI-07574 |
| MNDR | hsa-miR-125b-5p | Ovarian epithelial cancer | MNDR-E-MI-07575 |
| MNDR | hsa-miR-125b-5p | Esophageal squamous cell carcinoma | MNDR-E-MI-07576 |
| MNDR | hsa-miR-125b-5p | Uterine cervical neoplasms | MNDR-E-MI-07577 |
| MNDR | hsa-miR-125b-5p | Ependymoma | MNDR-E-MI-07578 |
| MNDR | hsa-miR-125b-5p | Cardiac hypertrophy | MNDR-E-MI-07579 |
| MNDR | hsa-miR-125b-5p | Nasopharyngeal cancer | MNDR-E-MI-07580 |
| MNDR | hsa-miR-125b-5p | Prostatic neoplasms | MNDR-E-MI-07581 |
| MNDR | hsa-miR-125b-5p | Sleep deprivation | MNDR-E-MI-07582 |
| MNDR | hsa-miR-125b-5p | Sepsis | MNDR-E-MI-07583 |
| MNDR | hsa-miR-125b-5p | Epstein-barr virus infections | MNDR-E-MI-07584 |
| MNDR | hsa-miR-125b-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-07585 |
| MNDR | hsa-miR-125b-5p | Gait ataxia | MNDR-E-MI-07586 |
| MNDR | hsa-miR-125b-5p | Paraparesis spastic | MNDR-E-MI-07587 |
| MNDR | hsa-miR-125b-5p | Delayed graft function | MNDR-E-MI-07588 |
| MNDR | hsa-miR-125b-5p | Stroke lacunar | MNDR-E-MI-07589 |
| MNDR | hsa-miR-125b-5p | Barrett's carcinogenesis | MNDR-E-MI-07590 |
| MNDR | hsa-miR-125b-5p | Breast cancer her3+ negative | MNDR-E-MI-07591 |
| MNDR | hsa-miR-125b-5p | Cerebellar neurodegeneration | MNDR-E-MI-07592 |
| MNDR | hsa-miR-125b-5p | Cutaneous squamous cell carcinoma | MNDR-E-MI-07593 |
| MNDR | hsa-miR-125b-5p | High grade dysplastic nodule | MNDR-E-MI-07594 |
| MNDR | hsa-miR-125b-5p | HPV | MNDR-E-MI-07595 |
| MNDR | hsa-miR-125b-5p | Neuroinflammation | MNDR-E-MI-07596 |
| MNDR | hsa-miR-125b-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-07597 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABTB1 | Homo sapiens | RR00027990 |
TOP